These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11320557)

  • 1. [Significance of medium molecular weight peptides in pathologic processes].
    Snarska J; Puchalski Z
    Pol Merkur Lekarski; 2001 Jan; 10(55):62-4. PubMed ID: 11320557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An effect of chromatographic fraction ultrafiltrate of plasma on aggregation of blood platelets in patients with chronic uremia].
    Popławski A; Myśliwiec M
    Pol Merkur Lekarski; 1996 Oct; 1(4):246-8. PubMed ID: 9156935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uremic middle molecules.
    Bergström J; Fürst P
    Clin Nephrol; 1976 Apr; 5(4):143-52. PubMed ID: 1277596
    [No Abstract]   [Full Text] [Related]  

  • 4. [Significance of peptides in the molecular etiology of uremic toxemia].
    Menyhárt J; Gróf J
    Orv Hetil; 1979 Jul; 120(30):1795-801. PubMed ID: 471491
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical value of determining the fibronectin level in internal diseases].
    Ena IaM; Konopleva LF; Chaialo AA; Sushko EA; Shekhter IE
    Klin Med (Mosk); 1991 Feb; 69(2):24-30. PubMed ID: 1875653
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on formation of complexes of insulin with basic peptides isolated from the plasma of uremic patients.
    Lutz W
    Acta Med Pol; 1975; 16(3):159-70. PubMed ID: 1180119
    [No Abstract]   [Full Text] [Related]  

  • 7. An overview of clinical implications of middle molecules and their kinetics in uremia.
    Funck-Brentano JL; Man NK
    Artif Organs; 1981; 4 Suppl():125-32. PubMed ID: 7295078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocyte glycolysis in uraemia: cynamic balance caused by the opposite action of various factors.
    Gajdos M; Dzúrik R
    Int Urol Nephrol; 1974; 5(3):331-6. PubMed ID: 4829138
    [No Abstract]   [Full Text] [Related]  

  • 9. Medium-sized peptides in the blood of patients with uremia.
    Mabuchi H; Nakahashi H
    Nephron; 1983; 33(4):232-7. PubMed ID: 6843753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Amino acid composition of peptides with molecular weight between 500 and 1500 daltons isolated from uremic and normal sera].
    Montagna G; Buzio C; Del Monte G; Manari A; Migone L
    Minerva Nefrol; 1980; 27(2):383-6. PubMed ID: 7219861
    [No Abstract]   [Full Text] [Related]  

  • 11. [Plasmapheresis as an optimal method to improve the outcome of surgical diseases].
    Genyk SN; Pidufalyĭ VR
    Sov Med; 1990; (7):33-41. PubMed ID: 2251560
    [No Abstract]   [Full Text] [Related]  

  • 12. Amino acid composition of uremic middle and low molecular weight retention products.
    Bazilinski N; Shaykh M; Ahmed S; Musiala T; Williams RH; Poulos A; Dubin A; Dunea G
    Adv Exp Med Biol; 1987; 223():197-204. PubMed ID: 3447436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of endoscopy in the diagnosis and treatment of lesions of the digestive system in patients with uremia].
    Aliev MA; Ioffe LTs; Kashkin KA; Goncharov AI; Ismagilov RZ
    Klin Khir (1962); 1987; (8):61-3. PubMed ID: 3682621
    [No Abstract]   [Full Text] [Related]  

  • 14. Separation of peptides of "middle" molecular weight from biological fluids of patients with uremia.
    Fürst P; Bergström J; Gordon A; Johnsson E; Zimmerman L
    Kidney Int Suppl; 1975 Feb; (3):272-5. PubMed ID: 1057698
    [No Abstract]   [Full Text] [Related]  

  • 15. Separation, identification of uremic middle molecules, and preliminary study on their toxicity.
    Li G; Chu J; Liu X; Yuan Z
    Clin Chim Acta; 2004 Dec; 350(1-2):89-98. PubMed ID: 15530464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Middle molecule peptides in the blood of patients with uremia].
    Kovalishin IaF; Baran EIa; Dudar' IA
    Lab Delo; 1987; (12):895-9. PubMed ID: 2449567
    [No Abstract]   [Full Text] [Related]  

  • 17. [Distribution of low- and medium-molecular-weight substances in biological fluids of healthy children].
    Gorbatova LN; Bebiakova NA; Sumarokova AV
    Fiziol Cheloveka; 2007; 33(1):114-8. PubMed ID: 17361616
    [No Abstract]   [Full Text] [Related]  

  • 18. [Plasma peptides].
    Sarnecka-Keller M
    Folia Med Cracov; 1974; 16(1):123-4. PubMed ID: 4838549
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cascade hemofiltration: principle, first experimental data].
    Rimmelé T; Hayi-Slayman D; Page M; Rada H; Monchi M; Allaouchiche B
    Ann Fr Anesth Reanim; 2009 Mar; 28(3):249-52. PubMed ID: 19282126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetic simulation of different modes of renal replacement therapy].
    Iakovleva II; Timokhov VS
    Anesteziol Reanimatol; 2004; (6):16-23. PubMed ID: 15717511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.